Vivo Capital, LLC Orchard Therapeutics PLC Transaction History

Vivo Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.16 - $2.23 $1.54 Million - $2.96 Million	-1,325,736 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$5.75 - $11.99 $1.73 Million - $3.61 Million	-301,489 Reduced 18.53%	1,325,736 $7.95 Million
Q1 2020 May 15, 2020	BUY	$5.65 - $15.71 $9.19 Million - $25.6 Million	1,627,225 New	1,627,225 $12.3 Million
Q3 2019 Nov 13, 2019	SELL	$11.88 - $16.72 $15.6 Million - $21.9 Million	-1,312,084 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$13.2 - $20.63 $11 Million - $17.1 Million	830,475 Added 172.44%	1,312,084 $18.4 Million
Q1 2019 May 14, 2019	SELL	$12.01 - $19.49 $3.97 Million - $6.44 Million	-330,285 Reduced 40.68%	481,609 $8.61 Million
Q4 2018 Feb 13, 2019	BUY	$12.4 - $18.7 $10.1 Million - $15.2 Million	811,894 New	811,894 $12.8 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.